199 related articles for article (PubMed ID: 7740452)
1. Alpha 1-antitrypsin Pittsburgh (Met358-->Arg) inhibits the contact pathway of intrinsic coagulation and alters the release of human neutrophil elastase during simulated extracorporeal circulation.
Wachtfogel YT; Bischoff R; Bauer R; Hack CE; Nuijens JH; Kucich U; Niewiarowski S; Edmunds LH; Colman RW
Thromb Haemost; 1994 Dec; 72(6):843-7. PubMed ID: 7740452
[TBL] [Abstract][Full Text] [Related]
2. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
[TBL] [Abstract][Full Text] [Related]
3. Thrombin and human plasma kallikrein inhibition during simulated extracorporeal circulation block platelet and neutrophil activation.
Wachtfogel YT; Kettner C; Hack CE; Nuijens JH; Reilly TM; Knabb RM; Kucich U; Niewiarowski S; Edmunds LH; Colman RW
Thromb Haemost; 1998 Oct; 80(4):686-91. PubMed ID: 9798991
[TBL] [Abstract][Full Text] [Related]
4. Nafamostat mesilate, a broad spectrum protease inhibitor, modulates platelet, neutrophil and contact activation in simulated extracorporeal circulation.
Sundaram S; Gikakis N; Hack CE; Niewiarowski S; Edmunds LH; Koneti Rao A; Sun L; Cooper SL; Colman RW
Thromb Haemost; 1996 Jan; 75(1):76-82. PubMed ID: 8713783
[TBL] [Abstract][Full Text] [Related]
5. Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulation.
Wachtfogel YT; Hack CE; Nuijens JH; Kettner C; Reilly TM; Knabb RM; Bischoff R; Tschesche H; Wenzel H; Kucich U
Am J Physiol; 1995 Mar; 268(3 Pt 2):H1352-7. PubMed ID: 7535008
[TBL] [Abstract][Full Text] [Related]
6. Effect of factor Xa inhibitors on thrombin formation and complement and neutrophil activation during in vitro extracorporeal circulation.
Gikakis N; Khan MM; Hiramatsu Y; Gorman JH; Hack CE; Sun L; Rao AK; Niewiarowski S; Colman RW; Edmunds LH
Circulation; 1996 Nov; 94(9 Suppl):II341-6. PubMed ID: 8901772
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte effects of C5a-receptor blockade during simulated extracorporeal circulation.
Rinder CS; Smith MJ; Rinder HM; Cortright DN; Brodbeck RM; Krause JE; Smith BR
Ann Thorac Surg; 2007 Jan; 83(1):146-52. PubMed ID: 17184649
[TBL] [Abstract][Full Text] [Related]
8. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation.
Rinder CS; Rinder HM; Smith MJ; Tracey JB; Fitch J; Li L; Rollins SA; Smith BR
J Thorac Cardiovasc Surg; 1999 Sep; 118(3):460-6. PubMed ID: 10469960
[TBL] [Abstract][Full Text] [Related]
9. Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment.
Schapira M; Ramus MA; Waeber B; Brunner HR; Jallat S; Carvallo D; Roitsch C; Courtney M
J Clin Invest; 1987 Aug; 80(2):582-5. PubMed ID: 3497179
[TBL] [Abstract][Full Text] [Related]
10. Blood activation during neonatal extracorporeal life support.
Plötz FB; van Oeveren W; Bartlett RH; Wildevuur CR
J Thorac Cardiovasc Surg; 1993 May; 105(5):823-32. PubMed ID: 7683735
[TBL] [Abstract][Full Text] [Related]
11. Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment.
Schapira M; Ramus MA; Jallat S; Carvallo D; Courtney M
J Clin Invest; 1986 Feb; 77(2):635-7. PubMed ID: 3484756
[TBL] [Abstract][Full Text] [Related]
12. Nafamostat preserves neutrophil deformability and reduces microaggregate formation during simulated extracorporeal circulation.
Hiramatsu Y; Homma S; Sato Y; Sato S; Matsuzaki K; Shigeta O; Sakakibara Y
Ann Thorac Surg; 2005 Apr; 79(4):1326-32. PubMed ID: 15797071
[TBL] [Abstract][Full Text] [Related]
13. Reactivity of alpha 1-antitrypsin mutants against proteolytic enzymes of the kallikrein-kinin, complement, and fibrinolytic systems.
Patston PA; Roodi N; Schifferli JA; Bischoff R; Courtney M; Schapira M
J Biol Chem; 1990 Jun; 265(18):10786-91. PubMed ID: 2191958
[TBL] [Abstract][Full Text] [Related]
14. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.
Nuijens JH; Abbink JJ; Wachtfogel YT; Colman RW; Eerenberg AJ; Dors D; Kamp AJ; Strack van Schijndel RJ; Thijs LG; Hack CE
J Lab Clin Med; 1992 Feb; 119(2):159-68. PubMed ID: 1740629
[TBL] [Abstract][Full Text] [Related]
15. Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.
Eldering E; Huijbregts CC; Nuijens JH; Verhoeven AJ; Hack CE
J Clin Invest; 1993 Mar; 91(3):1035-43. PubMed ID: 8450033
[TBL] [Abstract][Full Text] [Related]
16. Human neutrophil degranulation during extracorporeal circulation.
Wachtfogel YT; Kucich U; Greenplate J; Gluszko P; Abrams W; Weinbaum G; Wenger RK; Rucinski B; Niewiarowski S; Edmunds LH
Blood; 1987 Jan; 69(1):324-30. PubMed ID: 2947645
[TBL] [Abstract][Full Text] [Related]
17. Effects of simulated extracorporeal circulation on human leukocyte elastase release, superoxide generation, and procoagulant activity.
Stahl RF; Fisher CA; Kucich U; Weinbaum G; Warsaw DS; Stenach N; O'Connor C; Addonizio VP
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):230-9. PubMed ID: 1846928
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans.
Faymonville ME; Pincemail J; Duchateau J; Paulus JM; Adam A; Deby-Dupont G; Deby C; Albert A; Larbuisson R; Limet R
J Thorac Cardiovasc Surg; 1991 Aug; 102(2):309-17. PubMed ID: 1650868
[TBL] [Abstract][Full Text] [Related]
19. Iloprost reduces procoagulant activity in the extracorporeal circuit.
Korn RL; Fisher CA; Stenach N; Jeevanandam V; Addonizio VP
J Surg Res; 1993 Oct; 55(4):433-40. PubMed ID: 7692141
[TBL] [Abstract][Full Text] [Related]
20. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
